MAIA Biotechnology (MAIA) Return on Assets (2022 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Return on Assets of 0.02% for Q1 2026, up 1.0% year-over-year from 0.02% in Q1 2025, and up 50.59% quarter-over-quarter from 0.04% in Q4 2025.
MAIA Biotechnology (MAIA) Return on Assets (2022 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Return on Assets for 5 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets rose 1.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (up 1.0% YoY), while the FY2025 annual figure was 0.05%, down 1.0% from the prior year.
- Return on Assets climbed to 0.02% in Q1 2026 per MAIA's latest filing, from 0.04% in the prior quarter.
- Across five years, Return on Assets topped out at 0.02% in Q1 2026 and bottomed at 0.05% in Q1 2023.
- Historically, Return on Assets has averaged 0.03% across 5 years, with a median of 0.03% in 2024.
- Annual changes were most pronounced in 2023 — Return on Assets decreased 1 bps — and 2024, when it rose 2 bps.
- MAIA Biotechnology's Return on Assets stood at 0.03% in 2022, then slumped by 46 bps to 0.05% in 2023, then climbed by 15 bps to 0.04% in 2024, then decreased by 15 bps to 0.04% in 2025, then soared by 51 bps to 0.02% in 2026.
- Business Quant data shows MAIA's Return on Assets at 0.02% in Q1 2026, 0.04% in Q4 2025, and 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.04% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | -0.04% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.05% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.03% |